ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2015

Mar 7, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2015-03-04

Reporting Person: Myszkowski Kenneth Allen (CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-04	Common Stock	A	50000	—	Acquired	121500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-06	Stock Option	$7.75	A	50000	Acquired	2025-03-06	Common Stock (50000)	Direct

Footnotes

F1: Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments on the anniversary date of the grant.

F2: Option vests and becomes exercisable over a four year period from date of grant.